TY - JOUR
T1 - Reducing the global burden of cerebral venous thrombosis
T2 - An international research agenda
AU - Coutinho, Jonathan M
AU - van de Munckhof, Anita
AU - Aguiar de Sousa, Diana
AU - Poli, Sven
AU - Aaron, Sanjith
AU - Arauz, Antonio
AU - Conforto, Adriana Bastos
AU - Krzywicka, Katarzyna
AU - Hiltunen, Sini
AU - Lindgren, Erik
AU - van Kammen, Mayte Sánchez
AU - Shu, Liqi
AU - Bakchoul, Tamam
AU - Belder, Rosalie
AU - van den Berg, René
AU - Boumans, Elisheva
AU - Cannegieter, Suzanne
AU - Cano-Nigenda, Vanessa
AU - Field, Thalia S
AU - Fragata, Isabel
AU - Heldner, Mirjam R
AU - Hernández-Pérez, María
AU - Klok, Frederikus A
AU - Leker, Ronen R
AU - Lucas-Neto, Lia
AU - Molad, Jeremy
AU - Nguyen, Thanh N
AU - Saaltink, Dirk-Jan
AU - Saposnik, Gustavo
AU - Sharma, Pankaj
AU - Stam, Jan
AU - Thijs, Vincent
AU - van der Vaart, Michiel
AU - Werring, David J
AU - Wong Ramos, Diana
AU - Yaghi, Shadi
AU - Yeşilot, Nilüfer
AU - Tatlisumak, Turgut
AU - Putaala, Jukka
AU - Jood, Katarina
AU - Arnold, Marcel
AU - Ferro, José M
PY - 2024/3/17
Y1 - 2024/3/17
N2 - Background:Due to the rarity of cerebral venous thrombosis (CVT), performing high-quality scientific research in this field is challenging. Providing answers to unresolved research questions will improve prevention, diagnosis, and treatment, and ultimately translate to a better outcome of patients with CVT. We present an international research agenda, in which the most important research questions in the field of CVT are prioritized.Aims:This research agenda has three distinct goals: (1) to provide inspiration and focus to research on CVT for the coming years, (2) to reinforce international collaboration, and (3) to facilitate the acquisition of research funding.Summary of review:This international research agenda is the result of a research summit organized by the International Cerebral Venous Thrombosis Consortium in Amsterdam, the Netherlands, in June 2023. The summit brought together 45 participants from 15 countries including clinical researchers from various disciplines, patients who previously suffered from CVT, and delegates from industry and non-profit funding organizations. The research agenda is categorized into six pre-specified themes: (1) epidemiology and clinical features, (2) life after CVT, (3) neuroimaging and diagnosis, (4) pathophysiology, (5) medical treatment, and (6) endovascular treatment. For each theme, we present two to four research questions, followed by a brief substantiation per question. The research questions were prioritized by the participants of the summit through consensus discussion.Conclusions:This international research agenda provides an overview of the most burning research questions on CVT. Answering these questions will advance our understanding and management of CVT, which will ultimately lead to improved outcomes for CVT patients worldwide.
AB - Background:Due to the rarity of cerebral venous thrombosis (CVT), performing high-quality scientific research in this field is challenging. Providing answers to unresolved research questions will improve prevention, diagnosis, and treatment, and ultimately translate to a better outcome of patients with CVT. We present an international research agenda, in which the most important research questions in the field of CVT are prioritized.Aims:This research agenda has three distinct goals: (1) to provide inspiration and focus to research on CVT for the coming years, (2) to reinforce international collaboration, and (3) to facilitate the acquisition of research funding.Summary of review:This international research agenda is the result of a research summit organized by the International Cerebral Venous Thrombosis Consortium in Amsterdam, the Netherlands, in June 2023. The summit brought together 45 participants from 15 countries including clinical researchers from various disciplines, patients who previously suffered from CVT, and delegates from industry and non-profit funding organizations. The research agenda is categorized into six pre-specified themes: (1) epidemiology and clinical features, (2) life after CVT, (3) neuroimaging and diagnosis, (4) pathophysiology, (5) medical treatment, and (6) endovascular treatment. For each theme, we present two to four research questions, followed by a brief substantiation per question. The research questions were prioritized by the participants of the summit through consensus discussion.Conclusions:This international research agenda provides an overview of the most burning research questions on CVT. Answering these questions will advance our understanding and management of CVT, which will ultimately lead to improved outcomes for CVT patients worldwide.
U2 - 10.1177/17474930241242266
DO - 10.1177/17474930241242266
M3 - Article
SN - 1747-4949
JO - International Journal of Stroke
JF - International Journal of Stroke
ER -